Solution bio-inspired to meet needs of your contemporary practice better

Article

As practitioners, we should recognize the role contact lens solutions play in the overall success, satisfaction and ocular health of our contact lens patients.

A new and innovative multi-purpose solution (MPS) (Biotrue) from Bausch + Lomb can benefit soft contact lens-wearing patients. What separates this MPS from existing solutions is that it has several bio-inspired elements. The formulation was inspired by the eye to match the pH of healthy tears, to hydrate with the same lubricant found in the eye, and to keep certain beneficial proteins active.

What is bio-inspiration?

Bio-inspiration is also different from "biotechnology" or "bioengineering" which are disciplines that involve controlling or manipulating nature to achieve a specific goal.4,5 Rather, bio-inspiration mimics a process by which something is accomplished in nature; it is about using nature as a role model for innovation.

Bio-inspired products are everywhere-from our modes of transportation to clothing to products we depend upon to live, play, work, and communicate. Probably the most easily recognized bio-inspired products are hook and loop fasteners, of which the Velcro brand (Velcro USA Inc.) is the most well known. This product dates back to the 1940s and is based on the burdock seed that sticks to fur and hair through a series of hooks and loops.6

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.